These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 742112)

  • 21. [The differential treatment of patients with neurocirculatory dystonia depending on the type of hemodynamic disorders].
    Tatarintsev AN; Dvorkin AI; Semchenko VM
    Ter Arkh; 1993; 65(11):72-4. PubMed ID: 8108807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of sotalol in hyperkinetic heart syndrome: clinical evaluation and Holter dynamic electrocardiography].
    Gallo G; Foresti A
    Cardiologia; 1984; 29(3-4):237-54. PubMed ID: 6541942
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic problems in hyperkinetic heart syndrome].
    Rameis H; Magometschnigg D
    Acta Med Austriaca; 1984; 11(1):17-22. PubMed ID: 6143464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacologic effect of a beta-receptor blocking agent (LB-46) on hemodynamics].
    Köhler M
    Z Kreislaufforsch; 1970 Aug; 59(8):708-19. PubMed ID: 5513291
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative evaluation of the anti-arrhythmia effect of the antioxidant ionol (dibunol) in the arrhythmic form of neurocirculatory asthenia and stable exertion-induced stenocardia].
    Meerson FZ; Korochkin IM; Barbarash OL
    Sov Med; 1990; (3):67-70. PubMed ID: 1695023
    [No Abstract]   [Full Text] [Related]  

  • 26. [Length of effect of beta-blockers in hyperkinetic heart syndrome].
    Paulsen HF; Felder K
    ZFA (Stuttgart); 1983 Jul; 59(20):1149-54. PubMed ID: 6137915
    [No Abstract]   [Full Text] [Related]  

  • 27. Perceived exertion as an indicator of somatic stress.
    Borg G
    Scand J Rehabil Med; 1970; 2(2):92-8. PubMed ID: 5523831
    [No Abstract]   [Full Text] [Related]  

  • 28. [The influence of adrenergic block on the orthostatic changes of the integral vectors of QRS,T as well as the ventricle gradient in patients with neurocirculatory asthenia and thyrotoxicosis].
    Schweitzer P; Hildebrand T; Klvanová H; Simko S; Galajdová E; Gregorová J
    Z Kreislaufforsch; 1967 Mar; 56(3):316-25. PubMed ID: 4385192
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparative study of the effect of LB-46 and propranolol on central haemodynamic in cases with angina pectoris.
    Duner H; Pernow B
    Indian Heart J; 1972 Jun; 24():Suppl 1:180-2. PubMed ID: 4667014
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
    Lohmöller G; Middeke M; Mrowka C; Pötzl C; Renner W; Zoller W
    Med Klin (Munich); 1989 Feb; 84(2):81-5. PubMed ID: 2651861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography].
    Józan M; Tarján J; Wágner G; Rostás L; Lascsik L; Kovács S; Parti G
    Orv Hetil; 1981 Oct; 122(41):2547-8. PubMed ID: 6119668
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of age on the response to propranolol.
    Conway J
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):148-50. PubMed ID: 4924320
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of butydrine in various clinical syndromes (cardiovascular neurosis: juvenile hyperkinetic syndrome; thyrotoxicosis)].
    Guardigli R
    Minerva Cardioangiol; 1970 Feb; 18(2):131-40. PubMed ID: 4393800
    [No Abstract]   [Full Text] [Related]  

  • 34. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 35. [State of hemodynamics in patients with neurocirculatory dystonia].
    Synchuk AN
    Vrach Delo; 1977 May; (5):77-9. PubMed ID: 878427
    [No Abstract]   [Full Text] [Related]  

  • 36. [Amiodarone in long-term prevention of hyperkinetic cardiac disorders. Clinical experiments].
    Costa C; Guarini G
    Clin Ter; 1982 Aug; 102(4):337-48. PubMed ID: 7140184
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies of the significance of the electrocardiographic changes produced by orthostatism in patients with neurocirculatory asthenia].
    Zamfirescu NR; Petrea S; Ionescu V; Adamache A
    Fiziol Norm Patol; 1973; 19(5):405-20. PubMed ID: 4148175
    [No Abstract]   [Full Text] [Related]  

  • 38. [Coronary flow and and cardiac output of waking dogs during physical exertion under beta-receptor blockade].
    Kucharczyk M; Holtz J; Stoian D; Bassenge E
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):384-5. PubMed ID: 4397504
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension].
    Klein WW; Brandt D; Fluch N; Goebel R; Holzer H; Pöch G
    Adv Clin Pharmacol; 1976; 11():79-85. PubMed ID: 1032573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of several hypotensors on the working blood pressure and on the output in subjects with stage II hypertension (author's transl)].
    Chrástek J; Matousek O
    Cas Lek Cesk; 1977 Feb; 116(3):80-4. PubMed ID: 844063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.